Compensation to patient [Regulatives / Guidelines]

posted by Pharma_88 – India, 2025-01-22 14:02 (21 d 19:59 ago) – Posting: # 24344
Views: 506

Dear All,

For Bioequivalence study conducted on patients, do we need to provide financial compensation to patients for the participation i.e. Housing or blood loss for Pharmacokinetic evaluation? any guideline from DCGI/ICMR or any regulatory body?

Regards,
Pharma_88

Complete thread:

UA Flag
Activity
 Admin contact
23,380 posts in 4,914 threads, 1,661 registered users;
36 visitors (0 registered, 36 guests [including 8 identified bots]).
Forum time: 10:01 CET (Europe/Vienna)

Everything is trivial, if you know the answer.    Thomas Jaki

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5